Chapter 4 CNS Flashcards
Aminophylline/ Amphotericin/ Beclometasone/ Bendro/ Bumetanide & Lithium
Increased risk of hypokalaemia, potentially increased risk of torsades de pointes
Amiodarone/ Amisulpride / Citalopram & Lithium
Both prolong QT prolongation. Risk factors are age, female gender, cardiac disease, hypokalaemia predispose QT prolongation
Amitriptyline/ Carbamazepine & Lithium
Increased risk of neurotoxicity
Bendro / Benzydamide/ Captopril/ Candensartan & Lithium
Increased concentration of Lithium
When should the samples of lithium be taken?
Samples should be taken 12 hours after dose to achieve serum concentration of 0.4-1mmol/L
Monitoring requirements of lithium
- cardiac
- renal
- and thyroid before initiation of treatment
- monitor weight, ECG if cardio problem
- serum electrolytes and
- FBC
Lithium advice
Maintain fluid intake and avoid changing diet which increase or reduce sodium intake
Lithium toxicity
Report signs and symptoms of lithium toxicity
- renal dysfunction (polyuria and polydipsia)
- benign hypertension (persistent headache & visual disturbances)
- hypothyroidism
Lithium Withdrawal
Abrupt withdrawal of lithium, increase risk of relapse. This, it should be gradually reduced at least over a period of four weeks ( preferably up to 3 months)
Lithium in pregnancy
Advice for effective contraceptive methods during treatment for women with child bearing potential
Alcohol withdrawal
Abrupt withdrawal/ reduction of alcohol intake will lead to the development of alcohol withdrawal syndrome. Long acting benzos (diazepam) is recommended to attenuate alcohol withdrawal syndrome
Acamprosate in combo of psychological therapy
- maintenance of alcohol dependent
- 666mg OM and 333mg BD midday and night <60kg
- 666mg TDS >60kg
For 16-65years old
Disulfiram (alternative to acamprosate)
200mg daily (up to 500mg daily) Contraindications: cardiac and HTN
Disulfiram & Alcohol
- Avoid alcohol for (24hrs before treatment and for 14 days after treatment)
- Metronidazole & disulfiram risk of acute psychosis (no recommendation)
- Warfarin increases anticoagulant effect (monitor and adjust dose)
- phenytoin increases concentration